These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30002742)

  • 1. Predicting and Understanding Cancer Response to Treatment.
    Callari M; Gandellini P; Skvortsova I; Span PN
    Dis Markers; 2018; 2018():6159214. PubMed ID: 30002742
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected Articles from This Issue.
    Clin Cancer Res; 2020 May; 26(10):2279. PubMed ID: 32414759
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov.
    Vivot A; Li J; Zeitoun JD; Mourah S; Crequit P; Ravaud P; Porcher R
    Genet Med; 2016 Aug; 18(8):796-805. PubMed ID: 26681315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era).
    Franco R; Cantile M
    Curr Drug Targets; 2017; 18(1):2-3. PubMed ID: 27991404
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarker-Driven Treatments Yield Better Results.
    Cancer Discov; 2016 Aug; 6(8):OF4. PubMed ID: 27357459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maurie Markman on the Groundbreaking TAPUR Trial.
    Markman M
    Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
    Cavic M; Krivokuca A; Boljevic I; Brotto K; Jovanovic K; Tanic M; Filipovic L; Zec M; Malisic E; Jankovic R; Radulovic S
    J BUON; 2016; 21(5):1287-1295. PubMed ID: 27837635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
    Nair S; LLerena A
    Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
    [No Abstract]   [Full Text] [Related]  

  • 9. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
    Dienstmann R; Jang IS; Bot B; Friend S; Guinney J
    Cancer Discov; 2015 Feb; 5(2):118-23. PubMed ID: 25656898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paul Workman: Drugging the Cancer Genome.
    Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887
    [No Abstract]   [Full Text] [Related]  

  • 11. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 13. Selected Articles from This Issue.
    Mol Cancer Ther; 2020 Jul; 19(7):1383. PubMed ID: 32616655
    [No Abstract]   [Full Text] [Related]  

  • 14. PharmGKB summary: pazopanib pathway, pharmacokinetics.
    Thorn CF; Sharma MR; Altman RB; Klein TE
    Pharmacogenet Genomics; 2017 Aug; 27(8):307-312. PubMed ID: 28678138
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PharmGKB summary: sorafenib pathways.
    Gong L; Giacomini MM; Giacomini C; Maitland ML; Altman RB; Klein TE
    Pharmacogenet Genomics; 2017 Jun; 27(6):240-246. PubMed ID: 28362716
    [No Abstract]   [Full Text] [Related]  

  • 17. Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?
    Gyawali B
    J Natl Compr Canc Netw; 2017 Jul; 15(7):859-862. PubMed ID: 28687572
    [No Abstract]   [Full Text] [Related]  

  • 18. Homing in on genomic instability as a therapeutic target in cancer.
    Bielski CM; Taylor BS
    Nat Commun; 2021 Jun; 12(1):3663. PubMed ID: 34135330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.